{
    "2020-10-30": [
        [
            {
                "time": "2021-10-28",
                "original_text": "Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "AZN/JNJ",
                        "Coronavirus Vaccine",
                        "Resumption"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "Novo Nordisk's (NVO) Q3 Earnings Beat Estimates, Sales Miss",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Q3 Earnings",
                        "Beat Estimates",
                        "Sales Miss"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Incyte",
                        "Baricitinib",
                        "Alopecia Areata",
                        "Positive Data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "dermatology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "Eli Lilly Nabs $312.5M US Army Contract For Covid-19 Treatment",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "US Army",
                        "Covid-19 Treatment",
                        "Contract"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "government contracts"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "Eli Lilly Investor Alert",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Investor Alert"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}